Literature DB >> 23054535

Hybridization potential of oligonucleotides comprising 3'-O-methylated altritol nucleosides.

G Chatelain1, G Schepers, J Rozenski, Arthur Van Aerschot.   

Abstract

A series of 3'-O-methylated-d-altrohexitol nucleoside analogs (MANA) was synthesized comprising all four base moieties, adenine, cytosine, uracil, and guanine. These monomers were incorporated into oligonucleotides (ONs) by automated solid phase synthesis and the thermal and thermodynamic stability of all new modified constructs were evaluated. Data were compared with results obtained for both anhydrohexitol (HNAs) and 3'-O-altrohexitol-modified ONs (ANAs). We hereby demonstrate that ONs modified with MANA monomers have an improved thermal and thermodynamic stability compared to RNA, ANA, or HNA containing ONs of which the extent depends on the number of incorporated moieties and their position in the sequence. Thermodynamic analysis afforded comparable or even improved results in comparison with the incorporation of locked nucleic acids. While the specificity of these new synthons is slightly lower compared to mismatches within RNA double strands, it is similar to the discrimination potential of other hexitol modifications (HNA and ANA) which already proved their biologic interest, highlighting the potential of MANA constructs in antisense and in siRNA applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054535     DOI: 10.1007/s11030-012-9402-1

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  27 in total

1.  Argonaute2, a link between genetic and biochemical analyses of RNAi.

Authors:  S M Hammond; S Boettcher; A A Caudy; R Kobayashi; G J Hannon
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 2.  Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.

Authors:  Rakesh N Veedu; Jesper Wengel
Journal:  Chem Biodivers       Date:  2010-03       Impact factor: 2.408

3.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

4.  Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf.

Authors:  Michael Fisher; Mikhail Abramov; Arthur Van Aerschot; Jef Rozenski; Vidula Dixit; Rudy L Juliano; Piet Herdewijn
Journal:  Eur J Pharmacol       Date:  2009-01-30       Impact factor: 4.432

Review 5.  2'-Modified oligonucleotides for antisense therapeutics.

Authors:  Thazha P Prakash; Balkrishen Bhat
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

6.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

Review 7.  Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.

Authors:  Daniel De Paula; M Vitória L B Bentley; Ram I Mahato
Journal:  RNA       Date:  2007-02-28       Impact factor: 4.942

Review 8.  Antisense oligonucleotides made of 2'-O-alkylRNA: their properties and applications in RNA biochemistry.

Authors:  A I Lamond; B S Sproat
Journal:  FEBS Lett       Date:  1993-06-28       Impact factor: 4.124

9.  Improved hybridisation potential of oligonucleotides comprising O-methylated anhydrohexitol nucleoside congeners.

Authors:  A Van Aerschot; M Meldgaard; G Schepers; F Volders; J Rozenski; R Busson; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

10.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity.

Authors:  Jesper B Bramsen; Maria B Laursen; Anne F Nielsen; Thomas B Hansen; Claus Bus; Niels Langkjaer; B Ravindra Babu; Torben Højland; Mikhail Abramov; Arthur Van Aerschot; Dalibor Odadzic; Romualdas Smicius; Jens Haas; Cordula Andree; Jharna Barman; Malgorzata Wenska; Puneet Srivastava; Chuanzheng Zhou; Dmytro Honcharenko; Simone Hess; Elke Müller; Georgii V Bobkov; Sergey N Mikhailov; Eugenio Fava; Thomas F Meyer; Jyoti Chattopadhyaya; Marino Zerial; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.